Malaria vaccine receives Fast Track designation from FDA

Rockville, MD biotech company, Sanaria, announced Thursday that it has received U.S. Food and Drug Administration (FDA) Fast Track designation for its preventative vaccine for malaria, Sanaria(R) PfSPZ Vaccine. According to the FDA, "Fast Track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an ["]